Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
No, they have not...
The Big Question here is the $2.7M in stock. That's 20M shares at today's price. Many more at a discount. Is there a lock up period or are they going to dump on the market and kill this again.
I have sent an email to the company for specifics, however I am not holding my breath for a response...
https://www.linkedin.com/in/todd-caven-4a887415/
That is Correct...
https://www.otcmarkets.com/stock/HLYK/security
https://www.sec.gov/Archives/edgar/data/1518888/000121390020023823/xslF345X03/ownership.xml
https://www.sec.gov/Archives/edgar/data/1430860/000121390020018163/xslF345X03/ownership.xml
https://www.sec.gov/Archives/edgar/data/1804202/000121390020005282/xslF345X03/ownership.xml
https://www.sec.gov/Archives/edgar/data/1518647/000121390020006319/xslF345X03/ownership.xml
Growth Company Investor Presentations Now Available for On-Demand Viewing
https://www.virtualinvestorconferences.com/login-registration
$HLYK$ The $1.5 million of gross savings resulted in a shared savings payment of $767,743 to ACO Health Partners, its third consecutive year of shared savings.
https://www.otcmarkets.com/stock/HLYK/news/HealthLynked-Corp-Announces-ACO-Health-Partners-Earns-768k-in-Shared-Savings-Revenue-and-a-Fourfold-Growth-in-Covered-Me?id=276407
The $1.5 million of gross savings resulted in a shared savings payment of $767,743 to ACO Health Partners, its third consecutive year of shared savings.
https://www.otcmarkets.com/stock/HLYK/news/HealthLynked-Corp-Announces-ACO-Health-Partners-Earns-768k-in-Shared-Savings-Revenue-and-a-Fourfold-Growth-in-Covered-Me?id=276407
HealthLynked Corp. Announces ACO Health Partners Earns $768k in Shared Savings Revenue and a Fourfold Growth in Covered Medicare Beneficiaries
NAPLES, Fla., Oct. 8, 2020 /PRNewswire/ -- HealthLynked Corp. (OTCQB: HLYK), a global healthcare network focused on the care management of its members and healthcare technologies by connecting doctors, patients, and medical data, today announced ACO Health Partners, LLC, a Jacksonville based Accountable Care Organization (ACO) owned and managed by Cura Health Management, LLC, a wholly owned subsidiary of HealthLynked Corp, has reported its third consecutive year of shared savings.
According to recently released performance results from the Centers for Medicare and Medicaid Services "CMS", the federal agency that administers Medicare, ACO Health Partners improved care for its Medicare beneficiary population and reduced cost for Medicare by $1,535,487 while meeting its quality and cost goals in 2019.
Medicare data shows that ACO Health Partners also earned a positive quality score by meeting performance measures ranging from preventive health checks to use of computerized health records, as well as preventing avoidable hospitalizations. The $1.5 million of gross savings resulted in a shared savings payment of $767,743 to ACO Health Partners, its third consecutive year of shared savings. In addition, ACO Health Partners' ongoing Medicare beneficiary growth initiatives resulted in a four-fold increase in the ACO's covered beneficiary base to 11,500 going into the 2021 savings year. Savings are anticipated to grow at the same rate or better.
A market-based solution to combat fragmented and costly care, ACOs empower local physicians, hospitals, and other providers to work together and take responsibility for improving quality, enhancing patient experiences, and keeping care affordable. The Medicare Shared Savings Program (MSSP) creates incentives for ACOs to invest in transformative care solutions by allowing them to share in savings generated after meeting defined quality and cost goals.
"As the management organization for ACO Health Partners, our core work begins with using data analytics to identify opportunities to better address the needs of the patients in order to improve outcomes. When providers work together through an ACO to focus on patients and invest in care coordination and other care improvements, they can both increase quality and reduce costs" said Marsha Boggess, CEO of Cura Health Management. "This insight, coupled with actionable disease specific programs, equips our providers to prepare and execute effective care plans for patients, particularly those who need the most care. This patient-centric approach helps patients take advantage of preventive care programs such as annual wellness visits and recommended screenings, as well as programs designed to smooth transitions from facility care to home."
The ACO model served 11.2 million seniors and saved Medicare $2.6 billion in 2019. "These results reinforce the value ACOs have had on improving cost and quality within the Medicare population as well as the influence they have had on the rest of the healthcare system.", said Nicole Bradberry, CEO of the Florida Association of ACOs and advisor to HealthLynked. "The COVID-19 pandemic underscored the value that ACOs have brought to the table in the organized way they were able to help doctors respond to an unprecedented time. Initiatives such as telehealth and care coordination mitigated what could have been panic within the delivery system."
In addition to the positive 2019 results from CMS, multiple analyses have shown ACOs are lowering Medicare spending by 1 to 2 percent, which translates into tens of billions of dollars of reduced Medicare spending when compounded annually.
The Medicare ACO shared savings program is the largest value-based payment model in the country. HealthLynked entered this space in 2019 with the acquisition of ACO Health Partners and its management company, Cura Health Management. ACO Health Partners was one of 541 ACOs contributing to savings in 2019.
"We see ACOs as an important component of our business strategy, contributing to the health system as it moves to better value; for our patients, our providers and our shareholders," said George O'Leary, Chief Financial Officer, HealthLynked Corp. "We are committed to support our providers in this journey through enhanced infrastructure and programs as ACO Health Partners increased to 11,500 Medicare beneficiaries as we approach 2021."
https://www.otcmarkets.com/stock/HLYK/news/HealthLynked-Corp-Announces-ACO-Health-Partners-Earns-768k-in-Shared-Savings-Revenue-and-a-Fourfold-Growth-in-Covered-Me?id=276407
You posted incorrect information.
CEO is David Koos
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=158745393
I merely posted the link that confirmed what SanDiego stated.
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=158757423
On January 22, 2020 David Koos resigned...
Item 1.02 Termination of a Material Definitive Agreement.
On January 20, 2020 Regen Biopharma, Inc. (the “Company”) and BST Partners Inc. agreed that the month to month sublease by and between the Company and BST Partners, Inc. whereby the Company subleased office space from BST Partners, Inc.at 4700 Spring Street, St 304, La Mesa, California 91942 shall terminate as of 1pm Pacific Standard Time on January 22, 2020.
Item 5.02 Departure of Directors or Certain Officers
On January 22, 2020 David Koos resigned as Chairman of the Board of Directors, Chief Executive Officer of and from any and all offices held at Regen Biopharma, Inc. (the “Company”) as of 1 pm Pacific Standard Time on January 22, 2020 ( “Effective Date and Time”). As of the Effective Date and Time Todd S. Caven, the Company’s Chief Financial Officer and a member of the Board of Directors of the Company, shall be the Company’s sole officer and member of the Company’s Board of Directors.
On January 22, 2020 David Koos resigned as Chairman of the Board of Directors, Chief Executive Officer of and from any and all offices held at KCL Therapeutics, Inc. (KCL) as of 1 pm Pacific Standard Time on January 22, 2020 ( “Effective Date and Time”). As of the Effective Date and Time Todd S. Caven, KCL’s Chief Financial Officer and a member of the Board of Directors KCL, shall be KCL’s sole officer and member of KCL’s Board of Directors.
https://www.sec.gov/Archives/edgar/data/1589150/000160706220000023/rgbp012220form8k.htm
When I make investments into small companies such as Xallas, I always call the company to gauge the quality of the people I am putting my money behind.
I normally call after a PR or a filing to make sure that I am "seeing" everything that is written. As you very well know it sometimes takes several readings to fully digest.
The Tier II Offering sounds very exciting. And the SEC fully reporting gives the company a much more reputable standing to the Investment world.
All in All, I find Tom to be just what I want in a CEO.
On a side note. I opened an account at ATN and have talked to the company a couple times. They have a pretty cool setup. Very clear and easy. I have my strategies lined up and ready to go. I just need to get my Coinbase account funded.
Below is the contact information I have used to get in touch with the company.
www.xalles.com
905-299-9299
info@xalles.com
https://www.otcmarkets.com/stock/XALL/profile
One would have to assume that they were issued for acquisitions not yet announced as finalized in filings. Below are excepts from the latest filing (Page 40) for the Intel365 and the Argus deals.
eee) As of May 15, 2020, Xalles acquired 100% ownership of Intel365, Inc., closing the share exchange agreement that was entered into on April 27, 2020. As part of the agreement, the Intel365shareholders were issued 20,000,000 restricted common XALL shareson June 22, 2020.
fff) As of May 31, 2020, Xalles acquired 100% ownership of Argus Technology Partners, Inc., closing the share exchange agreement that was entered into on May 17, 2020. As part of the agreement, the Intel365shareholders were issued 28,000,000 restricted common XALL shareson June 24, 2020.
https://backend.otcmarkets.com/otcapi/company/financial-report/255498/content
September set the stage for growth in multiple directions. The deal with Commonwealth Primary Care ACO increases momentum.
https://www.marketscreener.com/quote/stock/HEALTHLYNKED-CORP-34790034/news/HealthLynked-Very-Active-In-September-Adds-Commonwealth-Primary-Care-ACO-To-Complete-A-String-Of-31491247/
Hey BigBoy. You are right..
PRPH is up 105% since the announcement. It does not take a rocket scientist to figure this one out.
From the 8K;
Item 1.01 Entry into a Material Definitive Agreement.
Consulting Agreement
Predictive Laboratories, (the “Company”) a wholly owned subsidiary of Predictive Technology Group, Inc. (trading under the symbol “PRED”) (Referred to hereinafter as PRED), includes a College of American Pathologists (“CAP”) accredited and Clinical Laboratory Improvement Amendment (“CLIA”) accredited laboratory that provides COVID-19 and other clinical laboratory services. On September 25, 2020 the Company entered into a Consulting Agreement with ProPhase Labs, Inc. (“Prophase Labs”) to assist Prophase Labs in developing additional COVID-19 testing capacity. This relationship does not limit the Company’s ability to provide COVID-19 and other clinical testing services, which are expected to continue without regard to the Consulting Agreement. The Consulting Agreement is effective from September 25, 2020 until September 1, 2022; provided, however, that Prophase Labs may terminate the Consulting Agreement at any time on five days’ prior written notice.
During the term of the Consulting Agreement, the Company will provide Prophase Labs with such regular and customary consulting advice as is reasonably requested by the Prophase Labs. The Company’s duties will also include, among other things, (i) identifying and introducing Prophase Labs to new opportunities in the medical technology and testing fields, (ii) assisting and advising Prophase Labs in acquiring one or more Clinical Laboratory Improvement Amendments (CLIA) accredited labs suitable for COVID-19 and other testing (“Test Labs”); (iii) assisting Prophase Labs in equipping and staffing any Test Labs acquired by the Company; (iv) advising and assisting in the operation of such Test Labs; (v) validating and obtaining certification of such Test Labs; and (vi) assisting Prophase Labs in obtaining a flow of business, orders and revenues from multiple sources in the industry, including but not limited to at least one significant, nation-wide manufacturer and distributor of COVID-19 saliva sample collection test kits (“Test Kits”).
https://www.sec.gov/Archives/edgar/data/1382943/000109181820000209/pred09302020form8k.htm
The Company filed an NT-10K last week giving them an extra 15 days. No different than many companies.
As stated in their filing, "State below in reasonable detail why Forms 10-K, 20-F, 11-K, 10-Q, 10-D, N-SAR, N-CSR, or the transition report or portion thereof, could not be filed within the prescribed time period.
The Company has encountered a delay in assembling the information required to be included in its Annual Report for the period ending June 30, 2020. The Company expects to file its June 30, 2020, Form 10-K Annual Report with the U.S. Securities and Exchange Commission within (15) calendar days of the prescribed due date."
The filing will be out Tuesday October 13th as stated on the TDA site.
https://www.sec.gov/Archives/edgar/data/1382943/000109181820000205/pred09282020nt10k.htm
Live Growth Opportunities Investor Conference October 8th
3:30 PM HealthLynked Corp. (OTCQB: HLYK)
https://www.marketwatch.com/press-release/live-growth-opportunities-investor-conference-october-8th-2020-10-05?mod=mw_quote_news
HealthLynked Corp. Partners with Commonwealth Primary Care Accountable Care Organization (ACO)
NAPLES, Fla., Oct. 1, 2020 /PRNewswire/ -- HealthLynked Corp. (OTCQB: HLYK), a global healthcare network focused on care management of its members and healthcare technologies connecting doctors, patients and medical data, today announced its collaboration with Commonwealth Primary Care ACO ("Commonwealth"). HealthLynked and Commonwealth will develop an innovative program to seamlessly share patient healthcare data among multiple providers. The goal of the partnership is to improve patient care, decrease duplicative testing and fill information gaps that exist between multiple providers treating the same patient.
Without accurate and up-to-date medical information, healthcare providers are often at a disadvantage in providing the best care for their patients. Patients often undergo duplicate testing and have longer in-office wait times to obtain medical records and are subject to a process that often leads to additional and unnecessary follow up visits and delays in diagnosis and treatment.
As more patients are seeing their healthcare providers via telemedicine, coordinating care among healthcare providers is more important than ever. Both online patient evaluation and care management are now reimbursable billing codes for private insurance companies and for Medicare. Reimbursement for these services is based on medical record exchange between providers and patients, including time spent reviewing records with each patient. To facilitate this process, there are nine separate billable codes available to the offices supporting the effort with reimbursements ranging from $16 to $53. There is no limit on the number of times a patient's record can be reviewed and exchanged between a healthcare provider and patient.
The HealthLynked Network and patient engagement technology is uniquely designed to allow physicians to easily connect with patients, exchange medical information, and provide patient guidance in partnership with Commonwealth. We believe that this partnership will be a model for other ACOs to improve outcomes, reduce cost, and more effectively coordinate patient care.
"We are excited to employ new and effective methods to provide our clinicians the most complete and up-to-date data on their patients. Many times, patients are being treated by multiple physicians in multiple settings and HealthLynked will allow us to seamlessly analyze all encounter data, coordinate care more effectively and deliver the most effective care at the right time and place," said Dr. Mark Goldberg, a Commonwealth Member of the Board of Trustees.
HealthLynked's CEO, Dr. Michael Dent, stated, "Working with Commonwealth to fill data gaps in patient care will optimize patient care and improve practice efficiencies. We believe this is the first of many collaborations and will serve as a model to work with other ACO partners."
About HealthLynked Corp.
HealthLynked Corp. provides a solution for both patient members and providers to improve healthcare through the efficient exchange of medical information. The HealthLynked Network is a cloud-based platform that allows members to connect with their healthcare providers and take more control of their healthcare. Members enter their medical information, including medications, allergies, past surgeries and personal health records, in one convenient online and secure location, free of charge. Participating healthcare providers can connect with their current and future patients through the system. Benefits to in-network providers include the ability to utilize the HealthLynked patent pending patient access hub "PAH" for patient analytics. Other benefits for preferred providers include HLYK marketing tools to connect with their active and inactive patients to improve patient retention, access more accurate and current patient information, provide more efficient online scheduling and to fill last minute cancelations using the Company's "real time appointment scheduling" all within its mobile application. Preferred providers pay a monthly fee to access these HealthLynked services. For additional information about HealthLynked Corp., please visit www.healthlynked.com and connect with HealthLynked on Twitter, Facebook, and LinkedIn.
About Commonwealth Primary Care ACO, LLC
Commonwealth is based in Tempe, AZ and is a collaboration of independent providers who seek to enhance the quality of healthcare while decreasing costs and improving outcomes for patients in Arizona. Commonwealth is primary-care based, owned, operated, and governed to provide innovation in-care practices for the continuous success of its independent offices and for the benefit of the members it serves. To accomplish this, Commonwealth provides not only business support and best practices, it collects and analyzes data that helps physicians coordinate care and increase communication. Commonwealth also operates as a federally chartered accountable care organization that operates in the greater Phoenix metropolitan area, Flagstaff, Tucson and throughout AZ as a participant in the Medicare Shared Savings Program.
https://www.otcmarkets.com/stock/HLYK/news/HealthLynked-Corp-Partners-with-Commonwealth-Primary-Care-Accountable-Care-Organization-ACO?id=275805
8-K Filed...
https://www.sec.gov/Archives/edgar/data/1550020/000149315220018269/form8-k.htm
eWellness Healthcare Corporation (OTC: “EWLL” and/or ‘the Company”) today announced that it has signed two new agreements with Bistromatics Inc. (“BI”), including at Business Operating Agreement (“BOA”) and a Marketing Partnership Agreement (“MPA”).
These agreements call for BI to immediately take over all operations and control of the PHZIO.COM, MSK360.COM and PREHABPT.COM platforms and websites from EWLL. As part of these agreements EWLL shall be granted a 15% ownership of BI. BI as part of this Agreement agrees to eliminate all past due professional fees of approximately US$782,832 owed to BI by EWLL. EWLL shall also be granted by BI a non-exclusive MPA for marketing of the PHZIO platform of products.
With the completion of these two new agreements the Company is in the early stages of re-position EWLL as a Value-Added Reseller (“VAR”) of the PHZIO & MSK360 platforms and potentially the marketing of other telehealth services in the future.
Information about PHZIO may be found at www.phzio.com.
DECN Announces Finalizing of International Genviro! COVID-19 Saliva Swift Kits for Global Market and Establishes Introductory Sales Pricing
https://www.otcmarkets.com/stock/DECN/news/DECN-Announces-Finalizing-of-International-Genviro-COVID-19-Saliva-Swift-Kits-for-Global-Market-and-Establishes-Introduc?id=274457
HealthLynked Corp. Launches Podcast Channel on Apple iTunes, Google, and Spotify
https://stockhouse.com/news/press-releases/2020/09/17/healthlynked-corp-launches-podcast-channel-on-apple-itunes-google-and-spotify
HealthLynked App and Wearable Health Sensor for Schools and Universities
https://www.healthlynked.com/wearable-health-sensor/?utm_source=vcm&utm_medium=social&utm_campaign=socialpost&fbclid=IwAR1DC4DYrQ6naQuFAVe3Hrb9W2rzrxI-lV1UvSDlsBL4xxrLJ_IwHazQLso
Plymouth, Massachusetts July 31, 2020 Plymouth Rock Technologies Inc. (CSE: PRT) (OTC: PLRTF) (Frankfurt: 4XA WKN# A2N8RH) (Plymouth Rock, PRT, or the Company) a leader in the development of cutting edge threat detection technologies, announced today that Thomas W. Nash, has joined the board of directors.
https://www.otcmarkets.com/stock/PLRTF/news/PLYMOUTH-ROCK-ANNOUNCES-BOARD-CHANGES?id=269367
It is my understanding that every time you have a material event (acquisition) while you are going through the Reg A approval process, an amendment has to be filed with the SEC.
With this being withdrawn, that should allow the company to complete the last 2 acquisitions, then get on with the Tier 2.
Looking forward to the closings of 1Rivet and Adaptive.
I view this as very positive...
"The Company plans to complete some audits to return to Fully SEC Reporting status and then subsequently file a new Form 1-A for a Tier II offering."
https://www.sec.gov/Archives/edgar/data/1581220/000156288420000017/xall-20200910_1awd.htm
Only $19K to take out the 0004's
$RGBP$ Report Covers Impacts of COVID-19 to the market.
The on-going pandemic has overhauled various facets of the market. This research report provides the financial impacts and market disturbance on the Hematopoietic Stem Cell Transplantation (HSCT) market. It also includes analysis on the potential lucrative opportunities and challenges in the foreseeable future. DataIntelo has interviewed various delegates of the industry and got involved in the primary and secondary research to confer the clients with information and strategies to fight against the market challenges amidst and after COVID-19 pandemic.
Market Segmentation:
Few of the companies that are covered in the report.
Regen Biopharma Inc
https://startupng.com.ng/news/160729/global-hematopoietic-stem-cell-transplantation-hsct-market-size-analytical-overview-growth-factors-demand-trends-and-forecast-to-2026/
$XALL$ Xalles is preparing to have a cryptocurrency technology-based trading solution ready to launch before the end of the third quarter, leveraging ATN Trading’s technology platform and the one-year-old partnership Xalles has with ATN. The recent strength in cryptocurrency is extremely favorable for our outlook, given Xalles Capital’s plans to acquire cryptocurrency assets in 2020.
https://www.otcmarkets.com/stock/XALL/news/Xalles-Holdings-Reviews-Q2-Achievements-and-2020-Outlook?id=271392
8-K Filed
https://www.sec.gov/Archives/edgar/data/1550020/000149315220016222/form8-k.htm
HealthLynked Reports 49% Year Over Year Revenue Growth
https://stockhouse.com/news/press-releases/2020/08/17/healthlynked-reports-49-year-over-year-revenue-growth-for-the-first-six-months
https://www.sec.gov/Archives/edgar/data/1680139/000121390020022223/f10q0620_healthlynked.htm
XALLES Reg A $3,000,000 @ $0.5025
"until the Reg A stock offering is SEC qualified, which we anticipate within a few weeks."
https://twitter.com/xalles1
Price per security
$ 0.5025
The portion of the aggregate offering price attributable to securities being offered on behalf of the issuer
$ 3000000.00
https://www.sec.gov/Archives/edgar/data/1581220/000156288420000004/xsl1-A_X01/primary_doc.xml
Raising money at $0.5025 when the price is currently at $0.025
One could say we are very undervalued !!!